Plus Therapeutics reported $8.15M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Baxter International USD 6.5B 3.82B Sep/2026
Cerus USD 34.78M 2.98M Dec/2024
Dr.Reddys Laboratories INR 74.82B 2.93B Sep/2026
Haemonetics USD 145.79M 448K Sep/2026
Northwest Biotherapeutics USD 11.39M 120.04M Mar/2026
Plus Therapeutics USD 8.15M 1.04M Mar/2026
Sanofi EUR 10.51B 598M Sep/2026
Starpharma Holdings AUD 11.7M 7.69M Dec/2025
Sun Pharmaceuticals INR 122.92B 5.49B Sep/2026
Teva Pharmaceutical Industries USD 3.18B 733M Sep/2026